Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 19

1.

Effects of HIV viremia on the gastrointestinal microbiome of young MSM.

Cook RR, Fulcher JA, Tobin NH, Li F, Lee D, Javanbakht M, Brookmeyer R, Shoptaw S, Bolan R, Aldrovandi GM, Gorbach PM.

AIDS. 2019 Apr 1;33(5):793-804. doi: 10.1097/QAD.0000000000002132.

PMID:
30649052
2.

Quantification of variation and the impact of biomass in targeted 16S rRNA gene sequencing studies.

Bender JM, Li F, Adisetiyo H, Lee D, Zabih S, Hung L, Wilkinson TA, Pannaraj PS, She RC, Bard JD, Tobin NH, Aldrovandi GM.

Microbiome. 2018 Sep 10;6(1):155. doi: 10.1186/s40168-018-0543-z.

3.

Effects of Substance Use and Sex Practices on the Intestinal Microbiome During HIV-1 Infection.

Fulcher JA, Hussain SK, Cook R, Li F, Tobin NH, Ragsdale A, Shoptaw S, Gorbach PM, Aldrovandi GM.

J Infect Dis. 2018 Oct 5;218(10):1560-1570. doi: 10.1093/infdis/jiy349.

PMID:
29982500
4.

A Method for Targeted 16S Sequencing of Human Milk Samples.

Tobin NH, Woodward C, Zabih S, Lee DJ, Li F, Aldrovandi GM.

J Vis Exp. 2018 Mar 23;(133). doi: 10.3791/56974.

5.

The importance of the microbiome in pediatrics and pediatric infectious diseases.

Gaufin T, Tobin NH, Aldrovandi GM.

Curr Opin Pediatr. 2018 Feb;30(1):117-124. doi: 10.1097/MOP.0000000000000576. Review.

6.

Breast milk and in utero transmission of HIV-1 select for envelope variants with unique molecular signatures.

Nakamura KJ, Heath L, Sobrera ER, Wilkinson TA, Semrau K, Kankasa C, Tobin NH, Webb NE, Lee B, Thea DM, Kuhn L, Mullins JI, Aldrovandi GM.

Retrovirology. 2017 Jan 26;14(1):6. doi: 10.1186/s12977-017-0331-z.

7.

Brief Report: Macrophage Activation in HIV-Infected Adolescent Males Contributes to Differential Bone Loss by Sex: Adolescent Trials Network Study 021.

Ruan A, Tobin NH, Mulligan K, Rollie A, Li F, Sleasman J, Aldrovandi GM.

J Acquir Immune Defic Syndr. 2016 Aug 1;72(4):372-5. doi: 10.1097/QAI.0000000000000953.

8.

A Conserved Glycan in the C2 Domain of HIV-1 Envelope Acts as a Molecular Switch to Control X4 Utilization by Clonal Variants with Identical V3 Loops.

Lombardi F, Nakamura KJ, Chen T, Sobrera ER, Tobin NH, Aldrovandi GM.

PLoS One. 2015 Jun 17;10(6):e0128116. doi: 10.1371/journal.pone.0128116. eCollection 2015.

9.

Are infants unique in their ability to be "functionally cured" of HIV-1?

Tobin NH, Aldrovandi GM.

Curr HIV/AIDS Rep. 2014 Mar;11(1):1-10. doi: 10.1007/s11904-013-0189-1.

PMID:
24390641
10.

Immunology of pediatric HIV infection.

Tobin NH, Aldrovandi GM.

Immunol Rev. 2013 Jul;254(1):143-69. doi: 10.1111/imr.12074. Review.

11.

An increasing proportion of monotypic HIV-1 DNA sequences during antiretroviral treatment suggests proliferation of HIV-infected cells.

Wagner TA, McKernan JL, Tobin NH, Tapia KA, Mullins JI, Frenkel LM.

J Virol. 2013 Feb;87(3):1770-8. doi: 10.1128/JVI.01985-12. Epub 2012 Nov 21.

12.

Quantification of mitochondrial toxicity in HIV-infected individuals by quantitative PCR compared to flow cytometry.

Wagner TA, Lin CH, Tobin NH, Côté HC, Sloan DD, Jerome KR, Frenkel LM.

Cytometry B Clin Cytom. 2013 Jan-Feb;84(1):55-8. doi: 10.1002/cyto.b.21045. Epub 2012 Oct 8.

13.

Increased mutations in Env and Pol suggest greater HIV-1 replication in sputum-derived viruses compared with blood-derived viruses.

Wagner TA, Tobin NH, McKernan JL, Xu M, Melvin AJ, Mohan KM, Learn GH, Mullins JI, Frenkel LM.

AIDS. 2009 May 15;23(8):923-8. doi: 10.1097/QAD.0b013e328329f964.

14.

Assessment of mitochondrial toxicity by analysis of mitochondrial protein expression in mononuclear cells.

Lin CH, Sloan DD, Dang CH, Wagner T, Cabrera AJ, Tobin NH, Frenkel LM, Jerome KR.

Cytometry B Clin Cytom. 2009 May;76(3):181-90. doi: 10.1002/cyto.b.20458.

15.

Density-dependent decay in HIV-1 dynamics.

Holte SE, Melvin AJ, Mullins JI, Tobin NH, Frenkel LM.

J Acquir Immune Defic Syndr. 2006 Mar;41(3):266-76.

PMID:
16540927
16.

Evidence that low-level viremias during effective highly active antiretroviral therapy result from two processes: expression of archival virus and replication of virus.

Tobin NH, Learn GH, Holte SE, Wang Y, Melvin AJ, McKernan JL, Pawluk DM, Mohan KM, Lewis PF, Mullins JI, Frenkel LM.

J Virol. 2005 Aug;79(15):9625-34.

17.

Understanding HIV-1 drug resistance.

Frenkel LM, Tobin NH.

Ther Drug Monit. 2004 Apr;26(2):116-21. Review.

PMID:
15228150
18.

Multiple viral genetic analyses detect low-level human immunodeficiency virus type 1 replication during effective highly active antiretroviral therapy.

Frenkel LM, Wang Y, Learn GH, McKernan JL, Ellis GM, Mohan KM, Holte SE, De Vange SM, Pawluk DM, Melvin AJ, Lewis PF, Heath LM, Beck IA, Mahalanabis M, Naugler WE, Tobin NH, Mullins JI.

J Virol. 2003 May;77(10):5721-30.

19.

Human immunodeficiency virus drug susceptibility and resistance testing.

Tobin NH, Frenkel LM.

Pediatr Infect Dis J. 2002 Jul;21(7):681-3. Review. No abstract available.

PMID:
12237603

Supplemental Content

Loading ...
Support Center